A detailed history of Cibc World Markets Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cibc World Markets Corp holds 22,393 shares of RPRX stock, worth $543,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,393
Previous 20,473 9.38%
Holding current value
$543,702
Previous $539,000 17.44%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.63 - $29.27 $49,209 - $56,198
1,920 Added 9.38%
22,393 $633,000
Q2 2024

Aug 12, 2024

BUY
$26.26 - $29.9 $129,409 - $147,347
4,928 Added 31.7%
20,473 $539,000
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $134,965 - $153,986
4,915 Added 46.24%
15,545 $472,000
Q4 2023

Feb 13, 2024

BUY
$26.21 - $29.22 $278,612 - $310,608
10,630 New
10,630 $298,000
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $21.9 Million - $24.6 Million
550,000 New
550,000 $22.1 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.